Skip to main content
LAZ logo

LAZ · Lazard, Inc.

Track LAZ — free
$39.39 +0.27 (+0.69%) At close · Nov 18
Market Cap
$4.32B
Shares
109.78M
Volume · Nov 18 1.4M Avg daily vol (3M) 1.63M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$39.39 Open$38.78 Day$38.70–40.15 52W close$34.66–57.00 Avg vol 30d1.6M Short int8.8M · 8.0% of shares · 4.5d Short vol69% Last earningsOct 22, 2026 DataJan 2020–Nov 2026 Filing10-Q · Oct 26

Up next

Jan 28, 2027 Est · unconfirmed · in 10 wks

Latest documents

2026
Nov 10
Investor event
CFO expects solid Q4 and compensation ratio normalization

Lazard CFO Tracy Farr expects a very, very solid Q4 and says the compensation ratio will spike in 26 before normalizing by the end of 28. She expects more back-office savings guidance no later than the first quarter discussion.

5 source passages
Tracy is the Chief Financial Officer of Lazard I think Q4, the way we view it, Thank you. I think it's going to be a very, very solid quarter. what that results, though, on a U.S. gap basis is a spike in 26 and then a quicker version in 27. The noise from that on an accounting basis kind of really rolls out by the end of 28, so that by the end of 28, we have kind of a normalized and very, very improved comp ratio. I would expect that no later than the first quarter discussion, we would be giving a lot more detail. Open the document at this passage
Nov 6
Current report 8-K
Resale prospectus covers 9,416,817 shares issued in Campbell Lutyens deal

Lazard filed a prospectus supplement for possible resale of up to 9,416,817 shares issued to selling stockholders in the acquisition of Campbell Lutyens Holdings Limited. Counsel Sullivan & Cromwell LLP opined the shares are validly issued and fully paid.

Other events
4 source passages
relating to the possible resale of up to 9,416,817 shares of the Company’s common stock issued to the selling stockholders in connection with the previously announced acquisition of one hundred percent of the outstanding ownership interests of Campbell Lutyens Holdings Limited Sullivan & Cromwell LLP, regarding the validity of the securities the Securities have been validly issued and are fully paid and nonassessable Open the document at this passage
Nov 2
Current report 8-K Events of Nov 1
Lazard Closes Campbell Lutyens Acquisition, Issuing 9,651,777 Shares

Lazard, Inc. completed its acquisition of Campbell Lutyens Holdings Limited on November 1, 2026. Initial consideration included 9,651,777 shares of common stock and approximately $93.2 million in cash, with $115 million deferred and up to $85 million in earn-out payments.

Entered into a material agreement, Unregistered sale of equity, Regulation FD disclosure Read from the first part of this long document
5 source passages
On November 1, 2026 (the “Closing Date”), Lazard, Inc., a Delaware corporation (the “Company”), completed its previously announced acquisition (the “Acquisition”) of one hundred percent of the outstanding ownership interests of Campbell Lutyens Holdings Limited consisted of (i) 9,651,777 shares of Common Stock (the “Initial Equity Consideration”) approximately $93.2 million in cash deferred consideration of $115 million payable on the second anniversary of the Closing Date contingent earn-out consideration of up to $85 million Open the document at this passage
Oct 26
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3

Lazard agreed to acquire Campbell Lutyens on April 30, 2026, for $460 million initial consideration, $115 million deferred consideration and up to $85 million in earn-outs; the transaction is expected to close in early November.

Revenue $836.38M ▲ 8.5% Net income $29.16M ▼ 59.1% Diluted EPS $0.26 ▼ 60.0%
Read from the MD&A section
Oct 22
Earnings call
Q3 2026 earnings call

Lazard plans to close its Camel Legends acquisition and launch Lizard CL in early November, expecting approximately $500 million of revenue and earnings accretion in 2027; financial advisory adjusted net revenue was $465 million.

All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$3.38B
Trailing 12 months
Net income (TTM)
$184.75M
Trailing 12 months
Revenue growth YoY
+8.5%
Year over year
Operating margin
7.9%
Trailing 12 months
P / E (TTM)
24.0
Trailing earnings · reciprocal yield 4.2%
FCF yield
15.8%
TTM · current market cap
Return on invested capital
14.1%
Trailing 12 months
Net cash
−$426.30M
Latest balance sheet
Dividend yield
5.1%
Trailing 12 months
Shares change YoY
-0.7%
Year over year · fewer shares
Price change (1Y)
-15.5%
Trailing year
Short interest
8.0%
Latest settlement · 4.5 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Oct 22, 2026
Q3 FY26

TL;DR. Lazard delivered 11% year-over-year adjusted net-revenue growth, record Financial Advisory revenue, stronger forward indicators and record asset-management inflows, while Lazard CL is expected to be accretive in 2027. However, adjusted earnings and operating margin declined year over year, the compensation ratio increased, nine-month Financial Advisory revenue fell, and Asset Management recorded third-quarter net outflows.

Bullish
  • + Firm-wide adjusted net revenue increased 11% year over year in the third quarter.
  • + Financial Advisory delivered record third-quarter revenue.
  • + The weighted 2027 pipeline is two times the 2026 pipeline at this time last year.
  • + Asset Management gross inflows reached a record $54 billion for the first nine months.
  • + Lazard CL is expected to generate approximately $500 million of revenue and be accretive to earnings in 2027 before synergies.
  • + Lazard returned $88 million to shareholders in the third quarter.
Bearish
  • − Adjusted net income declined 35% year over year in the third quarter.
  • − Adjusted diluted earnings per share declined 36% year over year in the third quarter.
  • − The adjusted compensation ratio increased to 69.9% from 65.5%.
  • − Financial Advisory adjusted net revenue declined 1% for the first nine months.
  • − The adjusted operating margin fell to 10.8% from 14.0% year over year.
  • − Asset Management recorded net outflows of $2.3 billion in the third quarter.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Sell Momentum Weak Sentiment Bullish Fundamentals Fair Quant / Vol High
Market backdrop VIX 24.6 · elevated Equity put/call 0.72
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −9%
below
Price vs 50-day avg +4%
above
RSI (14) 52
neutral
MACD trend Negative
52-week position 21%
mid-range
Momentum
relative strength
Weak
1-month return +5%
trailing
6-month return −17%
trailing
YTD return −19%
this year
Relative strength −13%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $38 › 200d $43 — 200d above 50d
Institutional flow Accumulating
+3% holders QoQ · +65 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
7.97% of shares out · ▼ -0.8% MoM · 4.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
360 holders — near 3-yr high, broad support
Squeeze score 66
elevated · 0–100
Fundamentals
Fair
Revenue growth +1%
Y/Y
EPS growth −19%
Y/Y
Free cash flow $487.4M
Valuation P/E 24
rich
Buyback $224.0K
remaining
Balance sheet $218.7M
net debt
Quant / Vol
risk profile
High
Volatility 43%
annualized · 1-yr
Max drawdown −39%
past year
ATR 4.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Jul 23, 2026
Productivity per MD · by 2028 $10M
Previous outlook earlier release · from the Earnings Call filed Oct 23, 2025

Still-open targets the latest release did not restate under the same label.

Average revenue per MD · 2030 $12.5M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−9% Bearish
Price vs 50-day avg
+4% Bullish
RSI (14)
52 Neutral
MACD trend
Negative Bearish
52-week position
21% Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $38 › 200d $43 — 200d above 50d
Institutional flow Accumulating
+3% holders QoQ · +65 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
7.97% of shares out · ▼ -0.8% MoM · 4.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
360 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $35 Now $39 · 21% Range high $57
vs 200-day avg -9% vs 50-day avg +4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted compensation and benefits expense, as a % of adjusted net revenue non-GAAP 69.9% Three Months Ended June 30, 2026 filing —
Adjusted net revenue non-GAAP $786.47M Three Months Ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Net revenue - U.S. GAAP basis 807.67M
-9.27M Revenue related to noncontrolling interests and similar arrangements (a)
-9.92M Gains related to LFI and other similar arrangements (b)
-26.93M Distribution fees, reimbursable deal costs, provision for credit losses and other (c)
+22.43M Interest expense (d)
+2.48M Gain on sale and deconsolidation of Edgewater (e)
= Adjusted net revenue 786.47M
Adjusted net revenue (Asset Management) non-GAAP $331.31M Three Months Ended June 30, 2026 filing —
Adjusted net revenue (Financial Advisory) non-GAAP $445.32M Three Months Ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Net revenue - U.S. GAAP basis 450.17M
-4.85M Reimbursable deal costs, provision for credit losses and other
+0K Interest expense
= Adjusted Net Revenue - Financial Advisory 445.32M
Adjusted non-compensation expense, as a % of adjusted net revenue non-GAAP 21.8% Three Months Ended June 30, 2026 filing —
Adjusted operating income (Asset Management) non-GAAP $74.43M Three Months Ended June 30, 2026 filing —
Adjusted operating income (Financial Advisory) non-GAAP $73.44M Three Months Ended June 30, 2026 filing —
Adjusted operating income, as a % of adjusted net revenue non-GAAP 8.3% Three Months Ended June 30, 2026 filing —
Adjusted operating income, as a % of adjusted net revenue (Asset Management) non-GAAP 22.5% Three Months Ended June 30, 2026 filing —
Asset Management adjusted operating income non-GAAP $74M Three Months Ended June 30, 2026 filing —
Average Alternative Investments AUM $9.64B Three Months Ended June 30, 2026 filing —
Average Equity AUM $210.3B Three Months Ended June 30, 2026 filing —
Average Fixed Income AUM $35.4B Three Months Ended June 30, 2026 filing —
Average Multi Asset AUM $23.78B Three Months Ended June 30, 2026 filing —
Financial Advisory Adjusted net revenue non-GAAP $445.32M Three Months Ended June 30, 2026 filing —
Financial Advisory Adjusted operating income non-GAAP $73.44M Three Months Ended June 30, 2026 filing —
Financial Advisory Adjusted operating income, as a % of adjusted net revenue non-GAAP 16.5% Three Months Ended June 30, 2026 filing —
Number of Financial Advisory clients with fees greater than $1 million 93 Three Months Ended June 30, 2026 filing —
Number of M&A transactions completed with values greater than $500 million 15 Three Months Ended June 30, 2026 filing —
Percentage of total Financial Advisory net revenue from top 10 clients 34% Three Months Ended June 30, 2026 filing —
Total Average AUM $279.12B Three Months Ended June 30, 2026 filing —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Capital Markets — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
LAZ
Lazard, Inc.
this stock
$4.32B -18.9% +1.5% 24.0 8.0%
MS
Morgan Stanley
$283.18B +2.1% +5.5% 14.4 1.0%
GS
Goldman Sachs Group Inc
$251.86B -0.7% +8.9% 12.6 2.2%
SCHW
Schwab Charles Corp
$159.76B -7.4% +22.0% 15.8 1.1%
HOOD
Robinhood Markets, Inc.
$62.29B -38.8% +51.6% 32.0 3.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
360
% held
83.4%
Net QoQ
-10.0M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
346
View
Short & Settlement
Short Interest Falling
Shares short
8.8M
Days to cover
4.5d
Change
-74.4K sh
View
Short Volume
Short vol %
69%
As of
Nov 18, 2026
Short Total
View
Fails to Deliver
FTD shares
163
Value
$6.0K
As of
Oct 21, 2026
View
Off-Exchange
Off-exchange %
46.7%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
James French Hill
Amount
$50.0K–$100.0K
Traded
Jun 23, 2025
View
Financials
Financials
Revenue (FY)
$3.2B
Net income (FY)
$236.8M
EPS diluted
$2.17
View
Buybacks
Authorized
$200.0M
Remaining
$224.0K
Spent Remaining
View
Filings
SEC Filings
Latest
Investor Event Transcript
Filed
Nov 10, 2026
This year
24

Lazard CFO Tracy Farr expects a very, very solid Q4 and says the compensation ratio will spike in 26 before normalizing by the end of 28. She expects more back-office savings guidance no later than the first quarter discussion.

View
Proposed Sales
Value
$5.4M
Shares
125.0K
Filed
Aug 25, 2026
View
Exempt Offerings
Offering
$648.8M
Filed
Nov 16, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Dec 8, 2026
Last webcast
Nov 10, 2026
View
Investor Relations
Latest news
Lazard Chief Financial Officer Tr…
Published
Nov 17, 2026
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
LAZ -6.0% +5.4% -16.8% +2.7% -18.9%
SPY -3.9% -5.6% -3.5% -3.4% +7.1%
vs SPY -2.1% +11.0% -13.3% +6.1% -26.0%

Capital returns

Latest dividend
$0.50 / share · ex Nov 2, 2026
Raised 6.4%
Paid (TTM)
$2.00 / share · 4 payouts
Dividend yield (TTM, derived)
5.08%
Full dividend history
Buyback program · as of Sep 30, 2026
Authorized
$200.00M
Spent (derived)
$199.78M
Remaining
$224,000
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1311370 CUSIP 52110M109 13F (30d) 344 filings 322 filers Visit website Investor relations